In a model of lupus nephritis, the HDAC inhibitor ITF2357 diminished the proinflammatory gene expression of il6, il-1β, and the systemic lupus erythematosus (SLE) serum biomarker IgG2a [65]. Here, IL1B is linked to systemic lupus erythematosus.